Today: 16 May 2026
Conagra Brands Stock Faces a 9% Dividend Test After Its Slide Deepens
25 April 2026
3 mins read

Conagra Brands Stock Faces a 9% Dividend Test After Its Slide Deepens

CHICAGO, April 25, 2026, 13:05 CDT

  • Wall Street’s renewed scrutiny of packaged-food sector payouts is drawing attention to Conagra’s dividend ahead of its April 30 record date.
  • The stock settled at $14.17 on Friday, logging another loss and hovering just above its 52-week low.
  • Conagra’s new chief executive steps in June 1. Inflation, tariffs, and sluggish consumer demand keep pressuring the company behind Slim Jim and Birds Eye.

BofA Securities has flagged Conagra Brands’ shaky shares for possible dividend cuts, putting the packaged-food group on a short list of payout risks, Barron’s said this weekend. Kraft Heinz, General Mills, and Campbell’s landed in the same boat, so it’s not just a Conagra story—concerns now stretch across the sector.

So why now? Conagra slid another 1.67% to close at $14.17 on Friday, logging its fifth consecutive loss. The drop has pushed the stock over 43% below its 52-week high, according to MarketWatch. That nearly 10% yield could catch the eye of income-focused investors—or just as easily point to skepticism over whether the payout is sustainable.

Timing’s a bit odd. Conagra’s board signed off on a 35-cent quarterly dividend, set for payment June 3 to shareholders registered as of April 30’s close. The company notes it hasn’t missed a quarterly dividend since January 1976.

Conagra’s margin for error looks thin heading into the debate. The company’s fiscal third-quarter numbers showed reported net sales down 1.9%, and adjusted earnings per share tumbling 23.5% to 39 cents. Management now expects full-year adjusted EPS to land around $1.70, which is the bottom of its earlier guidance. On the positive side, organic net sales—excluding things like currency swings and M&A—were up 2.4%. CEO Sean Connolly pointed to renewed organic growth, crediting frozen and snacks for the lift.

Cost remains the sticking point. Earlier this month, Reuters reported that Conagra is still bracing for roughly 7% inflation on its cost of goods in fiscal 2026—tariffs and pricier animal protein included. CEO Connolly noted that food companies have been “holding the line on pricing” as consumers “look for good value.” CFRA’s Arun Sundaram described the renewed organic growth as “a notable win,” but he flagged that keeping that momentum might mean reinvesting, which could squeeze margins. Reuters

Forecasts keep slipping. Morgan Stanley dropped its Conagra price target to $15 from $17 on April 23, sticking with an “equal weight” rating, according to MarketBeat. The site listed just one Buy, alongside 13 Hold and four Sell calls, for an average rating of “Reduce.” MarketBeat

BofA had already raised concerns about the dividend situation after Conagra brought in a new CEO. According to the firm, the payout ratio sits north of 80%, well above the intended range of 50% to 55%. Leverage is also elevated at 3.8 times net debt to EBITDA — that’s earnings before interest, taxes, depreciation and amortization, per Investing.com.

The dividend fight is coming just ahead of a leadership switch: John Brase, who previously held senior roles at J.M. Smucker and Procter & Gamble, steps in as president and CEO on June 1. Sean Connolly exits the CEO post and board the day before, on May 31. According to a filing, Brase’s pay package includes a $1.15 million base salary for fiscal 2027, a target annual cash bonus worth 150% of that base, and an annual equity grant valued at $7.3 million.

Board chair Richard H. Lenny called the timing “right” for a leadership shift at Conagra. John Brase set his focus on margin improvement and cash generation—words investors will parse amid the ongoing dividend discussion. Conagra Brands

Jefferies analyst Scott Marks described Brase’s arrival as bringing “fresh perspective” during a tough stretch for food companies. Marks noted that Conagra’s current challenge is a “difficult balancing act” — trying to repair finances while also pushing for reinvestment. It’s a tricky setup for the company, he said, both now and looking out over the next several quarters. Reuters

Earlier this month, two directors stepped in during the dip. SEC filings indicate Lenny picked up 25,000 shares on April 14, paying $14.34 apiece. On that same day, director John J. Mulligan bought 17,500 shares—his cost: $14.3087 each.

Here’s the risk: persistent consumer trade-down, stubbornly high input costs, or heavier tariff pressure could force the board into a tough call—protect the dividend, or pay down debt at a quicker clip. On the flip side, if costs ease, frozen-food demand holds, and Brase delivers better execution, Conagra might just steer the dividend through the turbulence.

Stock Market Today

  • Artemis Medicare Services' Earnings Boosted by Share Dilution, Raises Caution for Investors
    May 16, 2026, 1:08 AM EDT. Artemis Medicare Services (NSE:ARTEMISMED) reported strong earnings with a 25% profit increase in the last year, but share dilution raised the number of shares by 14%, softening earnings per share (EPS) growth to 22%. Over three years, profit rose 168%, while EPS grew 127%, highlighting dilution's impact. Dilution means each shareholder's piece of profit shrinks despite overall profit growth. Persistent EPS growth is crucial for true shareholder value and share price increase. Investors should examine additional factors such as margins, forecast growth, and return on investment to fully assess Artemis Medicare's earnings quality and future performance.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Enterprise Products Partners Stock Heads Into a Big Week as Dividend Clock Ticks
Previous Story

Enterprise Products Partners Stock Heads Into a Big Week as Dividend Clock Ticks

Realty Income Stock Just Stumbled Before Earnings. The Dividend Test Comes Next
Next Story

Realty Income Stock Just Stumbled Before Earnings. The Dividend Test Comes Next

Go toTop